59 SPXIQ

BIIB Biogen Inc.

Healthcare · Drug Manufacturers - General

$190.25 +8.1% upside
Mean Target
$205.67
Consensus
2.3 - Buy
Analysts
30
Rank
#105 / 499
Upside Rank
#288
Analyst Price Target Distribution
$143
Low
$206
Median
$206
Mean
$260
High
Current $190
Mean $206
Median $206
91 estimates
Consensus
2.3 - Buy
52-Wk Low
$110.04
52-Wk High
$202.41
50-Day Avg
$181.47
Recent Analyst Ratings
FirmRatingTargetPriorDate
Barclays Equal-Weight $185 2026-02-20
Wedbush Neutral $187 $178 2026-02-10
JP Morgan Neutral $230 $220 2026-02-09
Canaccord Genuity Buy $230 $220 2026-02-09
BMO Capital Market Perform $196 $165 2026-02-09
Healthcare Peers